Which are the leading cardiac marker testing business players?

Abbott, Becton, Dickinson and Company, Biom Read More

Home > Healthcare > Medical Devices > Diagnostic Devices > Cardiac Marker Testing Market

Cardiac Marker Testing Market Share

Report ID: GMI5614
Published Date: May 2023
Report Format: PDF

Download Free Sample

Cardiac Marker Testing Market Share

Some of the market players operating in the cardiac marker testing industry are :

Abbott
Becton
Dickinson and Company
Biomérieux SA
Bio-Rad Laboratories, Inc.
Creative Diagnostics
and Danaher Corporation

Several strategic initiatives such as novel product launches, strategic collaborations, and geographic expansion to gain competitive advantages are being undertaken. These prominent market players are adopting various organic as well as inorganic growth strategies to obtain competitive advantage and strengthen their market position.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size for cardiac marker testing was worth USD 8.5 billion in 2022 and will observe over 7.5% CAGR from 2023-2032 due to the growing burden of cardiovascular diseases worldwide.

Cardiac marker testing industry size from congestive heart failures may witness 8.9% CAGR from 2023-2032 owing to the rising rate of congestive heart failures and associated deaths.

North America market for cardiac marker testing will record more than USD 8 billion by 2032 due to the strong presence of major business players in the region.

Abbott, Becton, Dickinson and Company, Biom